| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Bioactive Materials Facilitating Targeted Local Modulation of Inflammation
|
Tan, Richard P.
|
|
|
4 |
1 |
p. 56-71
|
article
|
| 2 |
Cardiomyocyte SMAD4-Dependent TGF-β Signaling is Essential to Maintain Adult Heart Homeostasis
|
Umbarkar, Prachi
|
|
|
4 |
1 |
p. 41-53
|
article
|
| 3 |
Chest Compressions During Sustained Inflation During Cardiopulmonary Resuscitation in Newborn Infants Translating Evidence From Animal Studies to the Bedside
|
Schmölzer, Georg M.
|
|
|
4 |
1 |
p. 116-121
|
article
|
| 4 |
Circulating Pro-Vascular Progenitor Cell Depletion During Type 2 Diabetes
|
Terenzi, Daniella C.
|
|
|
4 |
1 |
p. 98-112
|
article
|
| 5 |
Connecting the Dots for Connective Tissue Growth Factor Roles in Cardiac Wound Healing After Myocardial Infarction ∗
|
Hale, Taben M.
|
|
|
4 |
1 |
p. 95-97
|
article
|
| 6 |
Connective Tissue Growth Factor Inhibition Enhances Cardiac Repair and Limits Fibrosis After Myocardial Infarction
|
Vainio, Laura E.
|
|
|
4 |
1 |
p. 83-94
|
article
|
| 7 |
Correction
|
|
|
|
4 |
1 |
p. 134
|
article
|
| 8 |
Dipeptidyl Peptidase-4 Inhibition Prevents Vascular Calcification by Potentiating the Insulin-Like Growth Factor-1 Signaling Pathway
|
Varennes, Olivier
|
|
|
4 |
1 |
p. 113-115
|
article
|
| 9 |
Editorial Board
|
|
|
|
4 |
1 |
p. i-iii
|
article
|
| 10 |
Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection Fraction
|
Connelly, Kim A.
|
|
|
4 |
1 |
p. 27-37
|
article
|
| 11 |
Full Issue PDF
|
|
|
|
4 |
1 |
p. I-CXLII
|
article
|
| 12 |
Instructions For Authors
|
|
|
|
4 |
1 |
p. iv-viii
|
article
|
| 13 |
It’s a SMAD, SMAD World
|
Bradshaw, Amy D.
|
|
|
4 |
1 |
p. 54-55
|
article
|
| 14 |
miR-29b Mediates the Chronic Inflammatory Response in Radiotherapy-Induced Vascular Disease
|
Eken, Suzanne M.
|
|
|
4 |
1 |
p. 72-82
|
article
|
| 15 |
Neutrophil Subsets, Platelets, and Vascular Disease in Psoriasis
|
Teague, Heather L.
|
|
|
4 |
1 |
p. 1-14
|
article
|
| 16 |
SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart
|
Lim, Ven G.
|
|
|
4 |
1 |
p. 15-26
|
article
|
| 17 |
The Growing Case for Use of SGLT2i in Heart Failure
|
Ha, Chae-Myeong
|
|
|
4 |
1 |
p. 38-40
|
article
|
| 18 |
Therapeutic Genome Editing in Cardiovascular Diseases
|
German, David M.
|
|
|
4 |
1 |
p. 122-131
|
article
|
| 19 |
What Are the Off-Target Effects of Plan “S” For Translational Investigators?
|
Mann, Douglas L.
|
|
|
4 |
1 |
p. 132-133
|
article
|
Journal description